Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study

Magnesium Research

Volumn 16, Issue 3, 2003, Pages 183-191

  Walker, Ann F ^a   Marakis, Georgios ^a   Christie, Samantha ^a   Byng, Martyn ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bioavailability; Magnesium; Mg amino acid chelate; Mg citrate; Mg oxide; RCT

Indexed keywords

CHELATE; MAGNESIUM AMINO ACID CHELATE; MAGNESIUM CITRATE; MAGNESIUM OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; ERYTHROCYTE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MAGNESIUM BLOOD LEVEL; MAGNESIUM EXCRETION; MAGNESIUM URINE LEVEL; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SUPPLEMENTATION; URINARY EXCRETION;

BIOLOGICAL AVAILABILITY; CHELATING AGENTS; CITRIC ACID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER; MAGNESIUM; MAGNESIUM OXIDE; MALE; ORGANOMETALLIC COMPOUNDS; SALIVA;

EID: 0242405540     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sabatier M., Arnaud M.J., Kastenmayer P., Rytz A., Barclay D.V. Meal effect on magnesium bioavailability from mineral water in healthy women. Am J Clin Nutr 2002; 75, 65-71.
2. Iannello S., Belfiore F. Hypomagnesemia. A review of pathophysiological, clinical and therapeutical aspects. Panminerva Medica 2001; 43, 177-209.
3. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001; 56, 163-170.
4. Moore T.J. The role of dietary electrolytes in hypertension. J Am Coll Nutr 1989; 8 Suppl. 68S-80S.
5. Morris M.E. Absorption of magnesium from orally administered magnesium sulfate in man. Clin Toxicol 1987; 25, 371-82.
6. Bøhmer T., Røseth A., Holm H., Weberg-Teigen L., Wahl L. Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnesium Trace Element 1990; 9, 272-8.
7. Lindberg J.S., Zobitz M.M., Poindexter J.R., Pak C.Y.C. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990; 9, 48-55.
8. Mühlbauer B., Schwenk M., Coram W.M., Antonin K.H., Etienne P., Bieck P.R., Douglas F.L. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol 1991; 40, 437-8.
9. Hoogerbrugge N., Cobbaert C., de Heide L., Birkenhager J.C. Oral physiological magnesium supplementation for 6 weeks with 1 g/d magnesium oxide does not affect increased Lp(a) levels in hypercholesterolaemic subjects. Magnesium Research 1996; 9, 129-32.
10. Sanjuliani A.F., de Abreu Fagundes V.G., Francischetti E.A. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol 1996; 56, 177-83.
11. DH (Department of Health) (1991). Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London: HMSO.
12. Walker A.F., De Souza M.C., Marakis G., Robinson P.A., Morris A.P., Bolland K.M. Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs. Med Hypotheses 2002; 58, 213-20.
13. Fischer P.W.F., Belonje B., Giroux A. Magnesium status and excretion in age-matched subjects with normal and elevated blood pressures. Clin Biochem 1993; 26, 207-11.
14. British Herbal Pharmacopeia (1983). British Herbal Medicine Association, PO Box 304, Bournemouth, BH7 6JZ, UK.
15. De Souza M.C. (1997) Magnesium supplementation in treatment of premenstrual syndrome. PhD Thesis, The University of Reading, UK.
16. Dunnett C. W. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955; 50, 1096-121.
17. Stedman's Medical Dictionary (1995): Twenty sixth edition. Williams, Wilkins, USA.
18. Firoz M., Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res 2001; 14, 257-62.
19. Djurhuus M.S., Gram J., Petersen P.H., Klitgaard N.A., Bollerslev J., Beck-Nielsen H. Biological variation of serum and urinary magnesium in apparently healthy males. Scand. J Clin Lab Invest 1995; 55, 549-58.
20. Izzo A.A., Gaginella T.S., Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of Mg sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res 1996; 9, 133-8.
21. Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001; 14, 283-90.
22. Gregory J., Foster K., Tyler H., Wiseman M. (1990). The Dietary and Nutritional Survey of British Adults. HMSO. London, UK.
23. Finch S., Doyle W., Lowe C., Bates C.J., Prentice A., Smithers G., Clarke P.C. (1998): National Diet, and Nutrition Survey: people aged 65 years and over. Volume 1: Report of the diet and nutrition survey. HMSO. London, UK.
24. Wilimzig C., Latz R., Vierling W., Mutschler E., Trnovec T., Nyulassy S. Increase in magnesium plasma level after orally administered trimagnesium dicitrate. Eur J Clin Pharmacol 1996; 49, 317-23.
25. Borella P., Bargellini G., Ambrosini G. Magnesium supplementation in adults with marginal deficiency: Response in blood indices, urine and saliva. Magnesium-Bulletin 1994; 16, 1-4.
26. Cole A.S., Eastoe J.E. (1994). Biochemistry and oral biology. Second edition. Wright ButterworthHeinemann Ltd, Oxford.
27. Kowalski W.J., Marcoin W. Estimation of bioavailability of selected magnesium organic salts by means of molecular modelling. Bollettino Chimico Farmaceutico 2001; 140, 322-8.
28. Sasaki S., Oshima T., Matsuura H., Ozono R., Higashi Y., Sasaki N., Matsumoto T., Nakano Y., Ueda, A., Yoshimizu, A., Kurisu, S., Kambe, M., Kajiyama, G. Abnormal magnesium status in patients with cardiovascular diseases. Clin Sci 2000; (Lond) 98, 175-81.